JP2000509067A5 - - Google Patents

Download PDF

Info

Publication number
JP2000509067A5
JP2000509067A5 JP1997538796A JP53879697A JP2000509067A5 JP 2000509067 A5 JP2000509067 A5 JP 2000509067A5 JP 1997538796 A JP1997538796 A JP 1997538796A JP 53879697 A JP53879697 A JP 53879697A JP 2000509067 A5 JP2000509067 A5 JP 2000509067A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997538796A
Other languages
English (en)
Japanese (ja)
Other versions
JP4233115B2 (ja
JP2000509067A (ja
Filing date
Publication date
Priority claimed from SE9601598A external-priority patent/SE508669C2/sv
Application filed filed Critical
Publication of JP2000509067A publication Critical patent/JP2000509067A/ja
Publication of JP2000509067A5 publication Critical patent/JP2000509067A5/ja
Application granted granted Critical
Publication of JP4233115B2 publication Critical patent/JP4233115B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53879697A 1996-04-26 1997-04-22 置換スルフィニル複素環式化合物のマグネシウム塩の製造法 Expired - Fee Related JP4233115B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9601598-7 1996-04-26
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande
PCT/SE1997/000674 WO1997041114A1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle

Publications (3)

Publication Number Publication Date
JP2000509067A JP2000509067A (ja) 2000-07-18
JP2000509067A5 true JP2000509067A5 (enExample) 2004-12-09
JP4233115B2 JP4233115B2 (ja) 2009-03-04

Family

ID=20402358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53879697A Expired - Fee Related JP4233115B2 (ja) 1996-04-26 1997-04-22 置換スルフィニル複素環式化合物のマグネシウム塩の製造法

Country Status (39)

Country Link
US (1) US6124464A (enExample)
EP (1) EP0897386B1 (enExample)
JP (1) JP4233115B2 (enExample)
KR (1) KR100468331B1 (enExample)
CN (1) CN1100776C (enExample)
AR (1) AR006640A1 (enExample)
AT (1) ATE222904T1 (enExample)
BR (1) BR9708829A (enExample)
CA (1) CA2251636C (enExample)
CZ (1) CZ295067B6 (enExample)
DE (1) DE69714987T2 (enExample)
DK (1) DK0897386T3 (enExample)
DZ (1) DZ2209A1 (enExample)
EE (1) EE03485B1 (enExample)
EG (1) EG23874A (enExample)
ES (1) ES2180981T3 (enExample)
HR (1) HRP970210B1 (enExample)
HU (1) HUP9901798A3 (enExample)
ID (1) ID16685A (enExample)
IL (1) IL126716A (enExample)
IS (1) IS1984B (enExample)
MA (1) MA24143A1 (enExample)
MY (1) MY119011A (enExample)
NO (1) NO318850B1 (enExample)
NZ (1) NZ332154A (enExample)
PL (1) PL188824B1 (enExample)
PT (1) PT897386E (enExample)
RS (1) RS49718B (enExample)
RU (1) RU2163238C2 (enExample)
SA (1) SA97170759B1 (enExample)
SE (1) SE508669C2 (enExample)
SI (1) SI0897386T1 (enExample)
SK (1) SK282752B6 (enExample)
TN (1) TNSN97068A1 (enExample)
TR (1) TR199802156T2 (enExample)
TW (1) TW420676B (enExample)
UA (1) UA51699C2 (enExample)
WO (1) WO1997041114A1 (enExample)
ZA (1) ZA973153B (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
DE19843413C1 (de) 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
WO2000028975A2 (en) 1998-11-18 2000-05-25 Astrazeneca Ab Improved chemical process and pharmaceutical formulation
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
DE60123800T2 (de) * 2000-08-04 2007-10-11 Takeda Pharmaceutical Co. Ltd. Salze von benzimidazol-derivaten und deren verwendung
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
PT1487818E (pt) * 2002-03-05 2007-07-18 Astrazeneca Ab Sais de alquilamónio de omeprazole e esomeprazole
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
EP1556043A1 (en) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Amorphous form of esomeprazole salts
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
CA2510849A1 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
BRPI0407906A (pt) * 2003-02-28 2006-02-14 Ranbaxy Lab Ltd polimorfos de s-omeprazol
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
ITMI20031813A1 (it) * 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US20080139623A1 (en) 2006-06-12 2008-06-12 Lilach Hedvati Amorphous and crystalline forms of pantoprazole magnesium salt
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
KR101522219B1 (ko) 2007-02-21 2015-05-21 시플라 리미티드 에소메프라졸 마그네슘 2수화물의 제조방법
US8106210B2 (en) * 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
EP2426111A1 (en) 2010-08-09 2012-03-07 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
CN103467453A (zh) * 2013-09-13 2013-12-25 上海海虹实业(集团)巢湖今辰药业有限公司 一种奥美拉唑镁原料药制备方法
CN106397399A (zh) * 2015-07-29 2017-02-15 陕西合成药业股份有限公司 一种泮托拉唑镁的精制方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
IL76837A0 (en) * 1984-10-31 1986-02-28 Byk Gulden Lomberg Chem Fab Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
FI861772L (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
US4851419A (en) * 1985-10-16 1989-07-25 Fisons Plc Certain 2-pyridinyl-phenylsulfinyl-benzoxazoles, the corresponding benzothiazoles or benzimidazoles having anti-inflammatory or gastric acid secretion inhibition activity
DD290192A5 (de) * 1986-11-13 1991-05-23 Eisai Co. Ltd,Jp Pyridinderivat mit antiulzeroeser wirkung
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
WO1989000566A1 (fr) * 1987-07-21 1989-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Composes de pyridine et leurs utilisations en medecine
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
EP0644191A1 (en) * 1992-06-01 1995-03-22 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and medicinal use thereof
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
US5374730A (en) * 1993-11-04 1994-12-20 Torcan Chemical Ltd. Preparation of omeprazole and lansoprazole
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2001503254A5 (enExample)
JP2000501771A5 (enExample)
JP2000512853A5 (enExample)
JP2000501599A5 (enExample)
JP2000500076A5 (enExample)
JP2000514461A5 (enExample)
JP2001525794A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2001502204A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000509067A5 (enExample)
JP2000501774A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)
JP2000509404A5 (enExample)
JP2000501569A5 (enExample)